Thomas B.
Cueni
Thomas B. Cueni is Director General of IFPMA, the global association of pharmaceutical research companies, based in Geneva and represents the innovative biopharmaceutical industry on the Access to COVID-19 Tools (ACT) Accelerator, a unique global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
Thomas B. Cueni
Thomas B. Cueni is Director General of IFPMA, the global association of pharmaceutical research companies, based in Geneva and represents the innovative biopharmaceutical industry on the Access to COVID-19 Tools (ACT) Accelerator, a unique global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines. He is Secretary of the global Biopharmaceutical CEO Roundtable (BCR), Chair AMR Industry Alliance, Chair of the Business at OECD Health Committee, and also serves on the Board of Directors of the City Cancer Challenge (CCan).
